Adrenal Androgen Excess and Body Mass Index in Polycystic Ovary Syndrome

被引:45
|
作者
Moran, Carlos [1 ]
Arriaga, Monica [2 ]
Arechavaleta-Velasco, Fabian [1 ]
Moran, Segundo [3 ]
机构
[1] Mexican Inst Social Secur, Hlth Res Council, Res Unit Reprod Med, Mexico City, DF, Mexico
[2] Mexican Inst Social Secur, Med Unit High Specialty, Gynecol & Obstet Hosp Luis Castelazo Ayala 4, Mexico City, DF, Mexico
[3] Mexican Inst Social Secur, Hlth Res Council, Res Unit Clin Epidemiol, Mexico City, DF, Mexico
来源
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2015年 / 100卷 / 03期
关键词
INSULIN-RESISTANCE; DEHYDROEPIANDROSTERONE-SULFATE; WOMEN; PREVALENCE; OBESITY; SECRETION; ENDOCRINE; HYPERANDROGENISM; HYPERINSULINEMIA; HORMONE;
D O I
10.1210/jc.2014-2569
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Adrenal hyperandrogenism affects approximately 25% of polycystic ovary syndrome (PCOS) patients but its relation to obesity is not totally understood. Objective: This study aimed to assess dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) levels in relation to body mass index (BMI) in PCOS. Design and Setting: This was a prospective observational study at an institutional practice at an obstetrics/gynecology hospital. Participants: The study included 136 PCOS patients, 20-35 years old, and 42 age-matched control women. The participants were classified with the BMI cutoff value of 27 kg/m(2) as follows: 1) high-BMI PCOS patients; 2) low-BMI PCOS patients; 3) high-BMI control women; and 4) low-BMI control women. The data were reanalyzed with the BMI cutoff value of 30 kg/m(2) to corroborate the findings in obese and nonobese patients. Main Outcome Measure(s): Blood samples were taken and LH, FSH, insulin, T, androstenedione (A4), DHEA, DHEAS, and glucose levels were determined. Homeostatic model assessment was calculated. Pelvic and abdominal ultrasound for ovarian morphology and adipose tissue, respectively, were performed. Results: Obese PCOS patients presented significantly more insulin resistance than nonobese PCOS patients. The LH levels and LH/FSH ratio were significantly higher in low-BMI than in high-BMI PCOS patients. The A4 and DHEAS levels were significantly higher in nonobese than in obese PCOS patients. Asignificant correlation between LH and A4 in nonobese PCOS patients was observed. The frequency of hyperandrogenism by increased A4, and DHEA along with DHEAS was significantly higher in low-BMI PCOS patients compared with high-BMI PCOS patients. Some findings observed with the BMI cutoff value of 27 kg/m(2) changed with the cutoff value of 30 kg/m(2). Conclusions: Low BMI more so than high BMI is associated with increased LH, high A4, DHEA, and DHEAS levels in PCOS patients. The BMI cutoff value of 27 kg/m(2) classified better than 30 kg/m(2) for hormonal and metabolic characteristics.
引用
收藏
页码:942 / 950
页数:9
相关论文
共 50 条
  • [41] The adrenal and polycystic ovary syndrome
    Yildiz, Bulent O.
    Azziz, Ricardo
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2007, 8 (04): : 331 - 342
  • [42] Adrenal androgen excess in hyperandrogenism:: relation to age and body mass
    Morán, C
    Knochenhauer, E
    Boots, LR
    Azziz, R
    FERTILITY AND STERILITY, 1999, 71 (04) : 671 - 674
  • [43] The adrenal and polycystic ovary syndrome
    Bulent O. Yildiz
    Ricardo Azziz
    Reviews in Endocrine and Metabolic Disorders, 2007, 8 : 331 - 342
  • [44] Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome
    Ciampelli, M
    Fulghesu, AM
    Cucinelli, F
    Pavone, V
    Ronsisvalle, E
    Guido, M
    Caruso, A
    Lanzone, A
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (02): : 167 - 172
  • [45] Alterations in Glucose Effectiveness and Insulin Dynamics: Polycystic Ovary Syndrome or Body Mass Index
    Vuguin, Patricia
    Sopher, Aviva B.
    Roumimper, Hailey
    Chin, Vivian
    Silfen, Miriam
    McMahon, Donald J.
    Fennoy, Ilene
    Oberfield, Sharon E.
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 87 (06): : 359 - 367
  • [46] The correlation of vitamin D level with body mass index in women with polycystic ovary syndrome
    Nowak, Artur
    Wojtowicz, Mariusz
    Baranski, Kamil
    Galczynska, Dominika
    Daniluk, Jakub
    Pluta, Dagmara
    GINEKOLOGIA POLSKA, 2023, 94 (11) : 883 - 888
  • [47] Effect of body mass index on in vitro fertilization outcomes in women with polycystic ovary syndrome
    Bailey, Amelia P.
    Hawkins, Leah K.
    Missmer, Stacey A.
    Correia, Katharine F.
    Yanushpolsky, Elena H.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 211 (02) : 163.e1 - 163.e6
  • [48] The association of body mass index and biochemical hyperandrogenaemia in women with and without polycystic ovary syndrome
    Yasmin, Ephia
    Balen, Adam H.
    Barth, Julian H.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 166 (02) : 173 - 177
  • [49] Birthweight, Childhood Body Mass Index, Height and Growth, and Risk of Polycystic Ovary Syndrome
    Aarestrup, Julie
    Pedersen, Dorthe C.
    Thomas, Peter E.
    Glintborg, Dorte
    Holm, Jens-Christian
    Bjerregaard, Lise G.
    Baker, Jennifer L.
    OBESITY FACTS, 2021, 14 (03) : 283 - 290
  • [50] Impact of body mass index on blood pressure levels in patients with polycystic ovary syndrome
    Barcellos, Cristiano R. G.
    Rocha, Michelle P.
    Hayashida, Sylvia A. Y.
    Mion Junior, Decio
    Lage, Silvia G.
    Marcondes, Jose A. M.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2007, 51 (07) : 1104 - 1109